October 14, 2022

Get Irked - Investments in Play - October 14, 2022

Click above image for larger version

The Week’s Biggest Winner & Loser

JPMorgan (JPM)

The banks were the stars of the show this week with earnings reports that blew away expectations. Best-in-Breed JPMorgan Chase (JPM) popped +4.92% following its Friday report which was enough, in this down week, to earn JPM the spot of the Week’s Biggest Winner.

Twilio (TWLO)

Companies that don’t generate income and, instead, lose money fall dramatically out of favor during Bear Markets. And since Twilio (TWLO) represents that remark in addition to being a stock from the high-growth tech sector, this week saw the once-darling fall from The Clouds to the tune of -17.66% earning it the spot of the Week’s Biggest Loser. Yowtch.

Portfolio Allocation

Click charts for enlarged versions

Positions

%

Target Position Size

Get Irked - Investments in Play - Current Holdings - October 14, 2022

Click above image for larger version

Portfolio Breakdown

Get Irked - Year-to-Date Performance - Investments in Play vs. Speculation in Play - 2022 Year-to-Date Performance

Click above image for larger version

Year-to-Date Performance

The “Baskets”

The Investments in Play portfolio contains a number of groups of stocks called “baskets.” I use baskets when I want exposure to a certain sector, but I want to use more than one stock to get that exposure without giving each individual stock an allocation.

In this portfolio, there is the Financials Basket which includes stocks that provide the portfolio with exposure to the financial sector which includes money-center banks, credit card companies, and investment management firms.

The Pets Basket includes the two leaders in pet health, long-time holding IDEXX Labs (IDXX) and newcomer Zoetis (ZTS). Both are considered “Best-in-Breed” (pun intended) for different reasons which is why I’m holding both of them instead of just picking one or over the other.

Additionally, there are two speculative baskets in the portfolio: Old-Spec and New-Spec.

Companies in the Old-Spec basket are ones with long track records where I want to have some exposure in the portfolio but I’m not confident enough to give each a full allocation.

New-Spec companies are typically stocks either new on the scene or representing a fairly new approach or sector, where, like Old-Spec, I want exposure but I don’t want a full allocation of any individual company.

Current Position Performance

Apple (AAPL)

+777.20%*

1st Buy 4/18/2013 @ $14.17
Current Per-Share: (-$54.05)*

Boeing (BA)

+540.67%*

1st Buy 2/14/2012 @ $79.58
Current Per-Share: (-$148.35)*

Tesla (TSLA)

+540.65%*

1st Buy 3/12/2020 @ $37.10
Current Per-Share: (-$26.14)*

Block (SQ)

+465.83%*

1st Buy 8/5/2016 @ $11.10
Current Per-Share: (-$71.45)*

Nvidia (NVDA)

+432.88%*

1st Buy 9/6/2016 @ $15.77
Current Per-Share:  (-$5.75)*

Nike (NKE)

+342.75%*

1st Buy 2/14/2012 @ $26.71
Current Per-Share: (-$3.59)*

IDEXX Labs (IDXX)

+309.54%*

1st Buy 7/26/2017 @ $167.29
Current Per-Share: (-$39.57)*

Skyworks (SWKS)

+283.21%*

1st Buy 1/31/2020 @ $113.60
Current Per-Share: (-$20.20)*

Logitech (LOGI)

+228.42%

1st Buy 11/11/2016 @ $24.20
Current Per-Share: $13.41

Disney (DIS)

+210.18%

1st Buy 2/14/2012 @ $41.70
Current Per-Share: $30.45

Amazon (AMZN)

+80.43%

1st Buy 2/6/2018 @ $69.15
Current Per-Share: $59.25

Meta (META)

+59.16%*

1st Buy 9/16/2017 @ $128.58
Current Per-Share: -($64.60)*

Take Two (TTWO)

+55.85%

1st Buy 10/9/2018 @ $128.40
Current Per-Share: $75.60

JP Morgan (JPM)

+46.11%

1st Buy 10/26/2017 @ $102.30
Current Per-Share: $76.10

Berkshire (BRK.B)

+45.22%

1st Buy 8/2/2019 @ $199.96
Current Per-Share: $187.77

Dow (DOW)

+37.11%

1st Buy 5/13/2019 @ $53.18
Current Per-Share: $32.91

Salesforce (CRM)

+23.94%

1st Buy 6/11/2018 @ $134.05
Current Per-Share: $114.75

Morgan Stan (MS)

-3.70%

1st Buy 4/25/2022 @ $83.50
Current Per-Share: $78.20

Visa (V)

-3.87%

1st Buy 5/9/2022 @ $194.00
Current Per-Share: $189.88

Schwab (SCHW)

-4.38%

1st Buy 4/18/2022 @ $76.30
Current Per-Share: $72.14

Alphabet (GOOGL)

-5.27%

1st Buy 9/16/2022 @ $101.93
Current Per-Share: $101.93

Zoetis (ZTS)

-6.02%

1st Buy 6/13/2022 @ $157.55
Current Per-Share: $154.71

Dutch Bros (BROS)

-14.92%

1st Buy 9/20/2021 @ $42.25
Current Per-Share: $36.60

Roblox (RLBX)

-22.78%

1st Buy 9/29/2021 @ $77.00
Current Per-Share: $46.05

Twilio (TWLO)

-42.34%

1st Buy 8/8/2019 @ $125.71
Current Per-Share: $109.73

Rivian (RIVN)

-51.67%

1st Buy 11/12/2021 @ $127.00
Current Per-Share: $59.40

Canopy (CGC)

-58.17%

1st Buy 5/24/2018 @ $29.53
Current Per-Share: $5.62

Coinbase (COIN)

-70.05%

1st Buy 4/14/2021 @ $412.47
Current Per-Share: $212.34

* Indicates a position where the capital investment was sold.
Profit % for * positions = Total Profit / Starting Capital Investment

A negative share price indicates the dollar amount of profit for each share currently held.

This Week’s Moves

Dutch Bros (BROS): Added to Position

Dutch Bros (BROS) broke through its $30.00 support early in the week and triggered my next buy order on Tuesday which filled at $28.15. The buy locked in a -35.27% discount replacing shares I sold for $43.49 back on August 3 and lowered my per-share cost -1.74% from $37.25 to $36.60.

From here, my next buy price target is $25.35, above a past point of support, and my next sell price target is $54.15, right at the high of BROS’ most recent rally in August.

BROS closed the week at $31.14, up +10.62% from where I added Tuesday.

Skyworks Solutions (SWKS): Added to Position

This week’s selloff continued to beat up the semiconductor industry, specifically, with Skyworks Solutions (SWKS) breaking through to new 2022 lows and triggering my next buy order which filled on Tuesday at $80.87.

The buy locked in a substantial -44.07% discount replacing some of the shares I sold for $144.59 back on December 17, 2021, and raised my per-share “cost” +$13.24 from -$33.44 to -$20.20 (a negative per-share cost indicates all capital has been removed in addition to $20.20 per share added to the portfolio’s bottom line in addition to each share’s current value). 

From here, my next buy price target is $68.45, slightly above SWKS’ pandemic bottom back in March 2020, and my next sell price target is $113.40, slightly below the high of Skyworks’ rally in August.

SWKS closed the week at $80.64, down -0.28% from where I added Tuesday.

Zoetis (ZTS): Added to Position

During Thursday morning’s selloff, Zoetis (ZTS) collapsed through my next buy target with my buy order filling at $142.07. The order lowered my per-share cost -1.60% down from $157.23 to $154.71.

From here, my next buy target is $131.55, above a past point of support, and my next sell target is $183.30, below the high from Zoetis’ rally in August.

ZTS closed the week at $145.40, up +2.34% from where I added Thursday.

Want Further Clarification?

As always, if you have questions about any of my positions or have positions of your own that you’re curious about – feel free to leave a comment below!

See you next week!

Don't get mad, Get Irked and learn how to invest for yourself!

 

Get Irked is a small community made up of helpful, friendly and motivated investors and traders of all levels looking to reach the same goal – the ability to invest profitably in order to achieve financial independence.

Investors of ALL experience levels are welcome.

Join Get Irked by clicking here!

Disclaimer: Eric “Irk” Jacobson and all other Get Irked contributors are not investment or financial advisers. All strategies, trading ideas, and other information presented comes from non-professional, amateur investors and traders sharing techniques and ideas for general information purposes. As always, all individuals should consult their financial advisers to determine if an investing idea is right for them. All investing comes with levels of risk with some ideas and strategies carrying more risk than others. As an individual investor, you are accountable for assessing all risk to determine if the strategy or idea fits with your investment style. All information on Get Irked is presented for educational and informational purposes only.